GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Issuance of Stock

Alto Neuroscience (Alto Neuroscience) Issuance of Stock : $137.58 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Issuance of Stock?

Alto Neuroscience's Issuance of Stock for the three months ended in Mar. 2024 was $137.58 Mil.

Alto Neuroscience's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was $137.58 Mil.


Alto Neuroscience Issuance of Stock Historical Data

The historical data trend for Alto Neuroscience's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Issuance of Stock Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Stock
0.01 0.04 0.18

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Issuance of Stock Get a 7-Day Free Trial - - - - 137.58

Alto Neuroscience Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $137.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alto Neuroscience Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Alto Neuroscience (Alto Neuroscience) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus